Ocrevus Approved to Treat Severe Form of Multiple Sclerosis

WEDNESDAY, March 29, 2017 — The injected drug Ocrevus (ocrelizumab) has been approved by the U.S. Food and Drug Administration to treat adults with primary progressive multiple sclerosis (PPMS) and relapsing forms of the disease, the agency said…
Source: Topamax